PrimeX News

Broker News

The Week Ahead: CPI, Retail Sales, Fed Speakers and AI Earnings Test Record Stock Rally
Sun, 10 May 2026 10:57:44 GMT
RBA Interest Rate Forecast: Oil, Inflation and China Shape AUDUSD and ASX 200
Sun, 10 May 2026 10:00:28 GMT
Bitcoin Weekly Outlook: BTC May Track Wall Street Rally To Hit $84K
Sun, 10 May 2026 10:58:29 GMT
Solana Price News: Short Liquidations for SOL Surpass BTC’s After $90 Breakout
Sat, 09 May 2026 22:08:35 GMT
Weak Banks and Tech Dragged ASX 200 Index as 500-SMA Support Comes Under Pressure
Sat, 09 May 2026 10:57:51 GMT
Trump Tariff Deadline Raises Risks for Stocks, Dollar and Treasury Yields
Sun, 10 May 2026 11:11:00 GMT

ECB, Bank of England Set to Hold Rates Unchanged Today
Thu, 30 Apr 2026 13:08:34 GMT
Nasdaq 100: Meta Falls as Amazon Slips, Microsoft, Alphabet Diverge
Wed, 29 Apr 2026 21:43:04 GMT
Hungary’s Euro Ambition Is a Long-term Bet Requiring Discipline, Credibility and Integration
Mon, 13 Apr 2026 16:16:44 GMT
A Divided Fed to Continue Favouring Easing Even as the Iran War Raises the Stakes
Thu, 26 Mar 2026 21:25:31 GMT
ECB Policy to Ultimately Be Determined by the Fallout from the Iran War
Mon, 16 Mar 2026 13:30:15 GMT
Jobs Miss and Oil Spike Signal Stagflation Risk for U.S. Economy
Fri, 20 Mar 2026 20:24:14 GMT

Getting an Edge From Factor Investing
Sat, 09 May 2026 10:43:54 GMT
US Sector Rotation Strategy: Using the Business Cycle & RRG Charts to Find Market Leaders
Sun, 03 May 2026 16:49:46 GMT
Silver (XAG) Forecast: Weak Below 50-Day MA, Silver Analysis Signals More Downside
Tue, 21 Apr 2026 17:29:23 GMT
What Are Leveraged and Inverse ETFs? Risks, Rewards, and Key Strategies
Mon, 23 Mar 2026 23:55:30 GMT
Bollinger Bands Trading Strategies: How to Read Volatility, Identify Market Regimes, and Trade with a Statistical Edge
Fri, 13 Mar 2026 22:59:16 GMT
Moving Averages Explained: A Beginner’s Guide to SMA and EMA Trading Strategies
Wed, 11 Mar 2026 17:49:10 GMT

Advertisement

Advertisement

NAMS

NewAmsterdam Pharma Company N.V. Ordinary Shares

38.73

USD

Sponsored

+3.88

+11.13%

May 08, 16:00 UTC -4

Closed

exchange

After-Market

38.72

-0.01

-0.03%

NAMS News & Forecasts

featured

NewAmsterdam Pharma Company N.V. (NAMS) Discusses Clinical Development Update and Interim Analysis Plans for PREVAIL Trial Transcript

featured

NewAmsterdam Pharma Sets PREVAIL Interim Analysis for Q4 2026 on Encouraging Blinded Trends

featured

Zacks Investment Research

NewAmsterdam Pharma Company N.V. (NAMS) Reports Q1 Loss, Tops Revenue Estimates

featured

NewAmsterdam Pharma: Cholesterol-Lowering Player Is A Risk-On Buy Today

Advertisement

Advertisement

Advertisement